Trending Up0.1900 (11.8012%)
  • Bid / Lots
    1.6500/ 2
  • Ask / Lots
    2.0500/ 10
  • Open / Previous Close
    1.6400 / 1.6100
  • Day Range
    Low 1.6200
    High 1.8477
  • 52 Week Range
    Low 1.4200
    High 5.2200
  • Volume
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.61
09:32 ET1761.64
09:34 ET7001.62
09:36 ET8001.62
09:38 ET13001.62
09:41 ET9301.62
09:43 ET1001.63
09:45 ET12001.62
09:50 ET1461.64
09:52 ET14001.64
09:56 ET12691.66
10:01 ET15901.67
10:03 ET21001.66
10:06 ET2001.69
10:12 ET51001.74
10:14 ET4001.7399
10:15 ET27701.7469
10:17 ET14001.7
10:24 ET5411.73
10:30 ET65001.7
10:32 ET1001.725
10:37 ET1001.725
10:42 ET54001.74
10:44 ET4261.71
10:53 ET66001.72
10:55 ET53001.72
10:57 ET17001.72
11:22 ET13181.726
11:24 ET23531.7
11:26 ET2281.7001
11:27 ET1001.7094
11:38 ET1001.71
11:47 ET10001.73
11:54 ET1001.73
12:12 ET6001.745
12:14 ET89351.72
12:21 ET22661.73
12:32 ET1701.75
12:34 ET27341.75
12:43 ET62001.74
12:54 ET15851.74
12:56 ET101641.76
01:01 ET3001.74
01:46 ET3001.7499
02:02 ET37001.75
02:06 ET1001.75
02:38 ET14001.73
03:03 ET5991.73
03:05 ET3001.77
03:07 ET18001.74
03:25 ET10001.76
03:27 ET1001.775
03:34 ET1001.7831
03:45 ET71991.7815
03:48 ET87631.79
03:50 ET44711.78
03:52 ET28001.81
03:57 ET15001.82
03:59 ET9441.8
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMAIA
Maia Biotechnology Inc
United StatesGNPX
Genprex Inc
United StatesINDP
Indaptus Therapeutics Inc
United StatesALZN
Alzamend Neuro Inc
United StatesAIM
AIM ImmunoTech Inc
United StatesSNSE
Sensei Biotherapeutics Inc
As of 2023-09-28

Company Information

MAIA Biotechnology, Inc. is a biopharmaceutical company. The Company is focused on developing oncology drug candidates to improve and extend the lives of people with cancer. The Company’s pipeline includes several targeted immuno-oncology therapies for difficult-to-treat cancers. The Company's THIO (6-thio-dG, 6-thio-2’-deoxyguanosine) is a potentially first-in-class small molecule that is a telomere-targeting agent in clinical development. THIO is followed by Libtayo for the treatment of advanced non-small-cell lung cancer. The Company is advancing THIO in Phase II clinical study in Non-Small Cell Lung Cancer. The Company's second-generation program is engaged in discovering new compounds with potentially improved specificity towards cancer cells relative to normal cells and with potentially increased anticancer activity. The second-generation pipeline of potential telomere-targeting agents includes five compounds that have undergone in vitro inhibitory testing in five cancer models.

Contact Information

444 West Lake Street Suite 1700, Suite 1700CHICAGO, IL, United States 60606


Chairman of the Board, President, Chief Executive Officer, Co-Founder
Vlad Vitoc
Chief Financial Officer
Joseph Mcguire
Chief Scientific Officer
Sergei Gryaznov
Chief Medical Officer
Mihail Obrocea
Independent Director
Steven Chaouki

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.